An Open-label Study of the Oral Administration of ASP8273 in Patients With Non-small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor (EGFR) Mutations
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00010672/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
Purpose of the study is to determine the following in patients with non-small cell lung cancer (NSCLC) harboring EGFR activating mutations.* the safety and tolerability of ASP8273.* the pharmacokinetics (PK) of ASP8273.* the antitumor activity of ASP8273.
提供机构：
Vivli
创建时间：
2024-10-10
